The use of ID migraine™ questionnaire in patients with multiple sclerosis

Veronica Villani, Luca Prosperini, Carlo Pozzilli, Marco Salvetti, Alessandro Ciuffoli, Giuliano Sette

Research output: Contribution to journalArticle

Abstract

Primary headaches are underdiagnosed and undertreated in patients with multiple sclerosis (MS). The aim of our study was to investigate the possibility of using the ID migraine™ (ID-M) questionnaire to make a first-line diagnosis of migraine in subjects affected by MS. We consecutively recruited 144 patients regularly attending the MS Centre of S. Andrea Hospital in Rome. Results from ID-M were matched with diagnoses of a blind neurologist. According to the ICHD-II criteria, 77 (53.5%) patients were diagnosed as suffering from migraine. ID-M showed high sensitivity (91%) and specificity (94%) in identifying patients with migraine. ID-M was also able to discriminate patients affected by headache following interferon beta therapy, having only the 10% out of these patients a positive ID-M. The use of the ID-M as a screening test is warranted not only in the epidemiological research, but also to ensure a better clinical management of patients with MS.

Original languageEnglish
Pages (from-to)269-273
Number of pages5
JournalNeurological Sciences
Volume32
Issue number2
DOIs
Publication statusPublished - Apr 2011

Keywords

  • Comorbidity
  • Disability
  • Headache
  • ID migraine questionnaire
  • Migraine
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Fingerprint Dive into the research topics of 'The use of ID migraine™ questionnaire in patients with multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this

    Villani, V., Prosperini, L., Pozzilli, C., Salvetti, M., Ciuffoli, A., & Sette, G. (2011). The use of ID migraine™ questionnaire in patients with multiple sclerosis. Neurological Sciences, 32(2), 269-273. https://doi.org/10.1007/s10072-010-0443-x